TY - JOUR T1 - Sex hormone and metabolic dysregulations are associated with critical illness in male Covid-19 patients JF - medRxiv DO - 10.1101/2020.05.07.20073817 SP - 2020.05.07.20073817 AU - Maria Schroeder AU - Berfin Schaumburg AU - Zacharias Müller AU - Ann Parplys AU - Dominik Jarczak AU - Axel Nierhaus AU - Andreas Kloetgen AU - Bettina Schneider AU - Manuela Peschka AU - Fabian Stoll AU - Tian Bai AU - Henning Jacobsen AU - Martin Zickler AU - Stephanie Stanelle-Bertram AU - Geraldine de Heer AU - Thomas Renné AU - Andreas Meinhardt AU - Joerg Heeren AU - Jens Aberle AU - Alice C. McHardy AU - Hartmut Schlüter AU - Jens Hiller AU - Sven Peine AU - Lothar Kreienbrock AU - Karin Klingel AU - Stefan Kluge AU - Gülsah Gabriel Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/20/2020.05.07.20073817.abstract N2 - Males develop more severe SARS-CoV-2 infection related disease outcome than females. Herein, sex hormones were repeatedly proposed to play an important role in Covid-19 pathophysiology and immunity. However, it is yet unclear whether sex hormones are associated with Covid-19 outcome in males and females. In this study, we analyzed sex hormones, cytokine and chemokine responses as well as performed a large profile analysis of 600 metabolites in critically-ill male and female Covid-19 patients in comparison to healthy controls and patients with coronary heart diseases as a prime Covid-19 comorbidity. We here show that dysregulated sex hormones, IFN-γ levels and unique metabolic signatures are associated with critical illness in Covid-19 patients. Both, male and female Covid-19 patients, present elevated estradiol levels which positively correlates with IFN-γ levels. Male Covid-19 patients additionally display severe testosterone and triglyceride deficiencies as compared to female patients and healthy controls. Our results suggest that male Covid-19 patients suffer from multiple metabolic disorders, which may lead to higher risk for fatal outcome. These findings will help to understand molecular pathways involved in Covid-19 pathophysiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the German Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Sampling from laboratory-confirmed Covid-19 patients was reviewed and approved by the ethics committee at the Hamburg State Chamber of Physicians (registration no.: WF-053/20). The need for an informed consent for healthy blood donors (HC) and patients with coronary heart diseases (CHD) was waived by the ethics committee because data were retrieved retrospectively from electronic health records.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll generated data are available in this study. No external repositories were used. ER -